UnitedHealth Group Incorporated filed its Form 10-Q with the Securities and Exchange Commission on August 10, 2026, covering the quarterly period ended June 30, 2026, and reporting second-quarter and first-half financial results across its consolidated operations.

Key Highlights

  • Total revenues reached $112,032 million for the three months ended June 30, 2026, compared with $111,616 million for the same period in 2025, according to the filing.
  • Net earnings attributable to UnitedHealth Group common shareholders were $5,484 million for the second quarter of 2026, versus $3,406 million in the second quarter of 2025.
  • Diluted earnings per share attributable to common shareholders were $6.04 for Q2 2026, compared with $3.74 for Q2 2025.
  • Medical costs for the six months ended June 30, 2026 were $148,847 million, down from $151,996 million in the same period of 2025.
  • Total assets stood at $309,727 million as of June 30, 2026, versus $309,581 million as of December 31, 2025.
  • Shares outstanding as of July 31, 2026 totaled 897,594,847 shares of common stock, $0.01 par value, the filing disclosed.

UnitedHealth Group Second-Quarter 2026 Revenue, Earnings, and Balance Sheet Details

According to the 10-Q filing, UnitedHealth Group (NYSE: UNH) reported total revenues of $112,032 million for the three months ended June 30, 2026, composed of premiums of $86,956 million, products revenue of $13,835 million, services revenue of $10,018 million, and investment and other income of $1,223 million. For the six months ended June 30, 2026, total revenues were $223,753 million, compared with $221,191 million for the same period in 2025.

The filing reported earnings from operations of $7,991 million for the second quarter of 2026, up from $5,150 million in the second quarter of 2025. After interest expense of $962 million and a loss on sale of subsidiary and subsidiaries held for sale of $61 million, earnings before income taxes were $6,968 million for Q2 2026. The provision for income taxes was $1,298 million, resulting in net earnings of $5,670 million for the quarter. Net earnings for the six months ended June 30, 2026 were $12,151 million, compared with $10,046 million for the six months ended June 30, 2025.

On the balance sheet, the company reported cash and cash equivalents of $28,585 million as of June 30, 2026, up from $24,365 million at December 31, 2025. Long-term debt, less current maturities, was $69,501 million at the end of the quarter, compared with $72,320 million at year-end 2025. Retained earnings were $100,957 million as of June 30, 2026, versus $95,603 million at December 31, 2025. Medical costs payable were $38,930 million at June 30, 2026, compared with $39,337 million at December 31, 2025. The basic weighted-average shares outstanding were 902 million for Q2 2026, and diluted weighted-average shares were 906 million.

What Was Disclosed

UnitedHealth Group's 10-Q for the period ended June 30, 2026 disclosed quarterly and year-to-date income statement results, balance sheet positions, earnings per share figures, and share counts, covering operations across its segments through the first half of 2026.